LOGIN
Timing of bisphosphonate administration does not affect fracture healing or complications
August 2013
Timing of bisphosphonate administration does not affect fracture healing or complications
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?
J Bone Joint Surg Br. 2012 Jul;94(7):956-60Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
90 osteoporotic patients, that have undergone fixation for an intertrochanteric fracture, were randomized to receive oral administration of a bisphosphonate (Risedronate) starting either one week, one month, or three months after surgery. The results demonstrate that the timing of bisphosphonate administration following hip fracture surgery does not affect time to fracture healing or incidence of ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.